These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 30096298)

  • 1. Pharmacological treatments for opiate and alcohol addiction: A historical perspective of the last 50 years.
    Blanco-Gandía MC; Rodríguez-Arias M
    Eur J Pharmacol; 2018 Oct; 836():89-101. PubMed ID: 30096298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addiction pharmacotherapy 2000: new options, new challenges.
    Rawson RA; McCann MJ; Hasson AJ; Ling W
    J Psychoactive Drugs; 2000; 32(4):371-8. PubMed ID: 11210198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapy for Alcohol Dependence: The 2015 Recommendations of the French Alcohol Society, Issued in Partnership with the European Federation of Addiction Societies.
    Rolland B; Paille F; Gillet C; Rigaud A; Moirand R; Dano C; Dematteis M; Mann K; Aubin HJ
    CNS Neurosci Ther; 2016 Jan; 22(1):25-37. PubMed ID: 26768685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetic treatments for drug addiction: alcohol and opiates.
    Haile CN; Kosten TA; Kosten TR
    Am J Drug Alcohol Abuse; 2008; 34(4):355-81. PubMed ID: 18584566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapy of alcohol dependence: a review of the clinical data.
    Mann K
    CNS Drugs; 2004; 18(8):485-504. PubMed ID: 15182219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapies in early development for the treatment of opiate addiction.
    Rodríguez-Arias M; Aguilar MA; Miñarro J
    Expert Opin Investig Drugs; 2015; 24(11):1459-72. PubMed ID: 26414784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opiate addiction and the locus coeruleus. The clinical utility of clonidine, naltrexone, methadone, and buprenorphine.
    Gold MS
    Psychiatr Clin North Am; 1993 Mar; 16(1):61-73. PubMed ID: 8456048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New pharmacological treatment strategies for relapse prevention.
    Spanagel R; Vengeliene V
    Curr Top Behav Neurosci; 2013; 13():583-609. PubMed ID: 22389180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of precipitated opiate withdrawal syndrome induced by nalmefene mistakenly prescribed in opiate-dependent patients: a review for clinicians.
    Franchitto N; Jullian B; Salles J; Pelissier F; Rolland B
    Expert Opin Drug Metab Toxicol; 2017 Jun; 13(6):669-677. PubMed ID: 28343423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid Receptor Antagonists in the Treatment of Alcoholism.
    Serecigni JG
    Adicciones; 2015 Sep; 27(3):214-30. PubMed ID: 26437315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale for maintenance pharmacotherapy of opiate dependence.
    Kreek MJ
    Res Publ Assoc Res Nerv Ment Dis; 1992; 70():205-30. PubMed ID: 1346939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personalized Medicine of Alcohol Addiction: Pharmacogenomics and Beyond.
    Ragia G; Manolopoulos VG
    Curr Pharm Biotechnol; 2017; 18(3):221-230. PubMed ID: 28240173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current concepts in pharmacotherapy of substance abuse.
    Gottschalk PC; Jacobsen LK; Kosten TR
    Curr Psychiatry Rep; 1999 Dec; 1(2):172-8. PubMed ID: 11122921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term course of opioid addiction.
    Hser YI; Evans E; Grella C; Ling W; Anglin D
    Harv Rev Psychiatry; 2015; 23(2):76-89. PubMed ID: 25747921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurobiology of addictive behaviors and its relationship to methadone maintenance.
    Stimmel B; Kreek MJ
    Mt Sinai J Med; 2000; 67(5-6):375-80. PubMed ID: 11064487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescription procedures in medication for relapse prevention after inpatient treatment for alcohol use disorders in Switzerland.
    Buri C; Moggi F; Giovanoli A; Strik W
    Alcohol Alcohol; 2007; 42(4):333-9. PubMed ID: 17517820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New achievements and pharmacotherapeutic approaches in the treatment of alcohol dependence.
    Kiefer F; Mann K
    Eur J Pharmacol; 2005 Dec; 526(1-3):163-71. PubMed ID: 16266700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy for Substance Use Disorders.
    Klein JW
    Med Clin North Am; 2016 Jul; 100(4):891-910. PubMed ID: 27235620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive effects of labeled addictolytic medications.
    Pujol CN; Paasche C; Laprevote V; Trojak B; Vidailhet P; Bacon E; Lalanne L
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():306-332. PubMed ID: 28919445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical evidence of new opioid modulators for the treatment of addiction.
    Rodríguez-Arias M; Aguilar MA; Manzanedo C; Miñarro J
    Expert Opin Investig Drugs; 2010 Aug; 19(8):977-94. PubMed ID: 20629615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.